Evidence Table 2Results of tests for detection of factor V leiden


Reference List
  1. Hertzberg M, Neville S, Favaloro E, McDonald D. External quality assurance of DNA testing for thrombophilia mutations. Am J Clin Pathol 2005; 123(2):189–93.
  2. Jennings I, Kitchen S, Woods TA, Preston FE. Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program. Semin Thromb Hemost 2005; 31(1):66–72.
  3. Angeline T, Bentley HA, Hawk AB et al. Prevalence of the Factor V G1691A and the Factor II/prothrombin G20210A gene polymorphisms among Tamilians. Exp Mol Pathol 2005; 79(1):9–13.
  4. Nauck M, Marz W, Wieland H. Evaluation of the Roche diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit. Clin Biochem 2000; 33(3):213–6.
  5. Parks SB, Popovich BW, Press RD. Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypes. Am J Clin Pathol 2001; 115(3):439–47.
  6. Ledford M, Friedman KD, Hessner MJ, Moehlenkamp C, Williams TM, Larson RS. A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay. J Mol Diagn 2000; 2(2):97–104.
  7. Moser MJ, Marshall DJ, Grenier JK et al. Exploiting the enzymatic recognition of an unnatural base pair to develop a universal genetic analysis system. Clin Chem 2003; 49(3):407–14.
  8. Castley A, Higgins M, Ivey J, Mamotte C, Sayer DC, Christiansen FT. Clinical applications of whole-blood PCR with real-time instrumentation. Clin Chem 2005; 51(11):2025–30.
  9. Hessner MJ, Budish MA, Friedman KD. Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. Clin Chem 2000; 46(8 Pt 1):1051–6.
  10. Cooper PC, Cooper SM, Smith JM, Kitchen S, Makris M. Evaluation of the Roche LightCycler: a simple and rapid method for direct detection of factor V Leiden and prothrombin G20210A genotypes from blood samples without the need for DNA extraction. Blood Coagul Fibrinolysis 2003; 14(5):499–503.
  11. Schroell-Metzger B, Dicato M, Bosseler M, Berchem G. Comparison of standard PCR and the LightCycler technique to determine the thrombophilic mutations: an efficiency and cost study. Clin Chem Lab Med 2003; 41(4):482–5.
  12. Liew M, Pryor R, Palais R et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem 2004; 50(7):1156–64.
  13. Sanders Sevall J. Factor V Leiden genotyping using real-time fluorescent polymerase chain reaction. Mol Cell Probes 2000; 14(4):249–53.
  14. Behrens M, Lange R. A highly reproducible and economically competitive SNP analysis of several well characterized human mutations. Clin Lab 2004; 50(5–6):305–16.
  15. Louis M, Dekairelle AF, Gala JL. Rapid combined genotyping of factor V, prothrombin and methylenetetrahydrofolate reductase single nucleotide polymorphisms using minor groove binding DNA oligonucleotides (MGB probes) and real-time polymerase chain reaction. Clin Chem Lab Med 2004; 42(12):1364–9.
  16. Benson JM, Ellingsen D, El-Jamil M et al. Factor V Leiden and factor V R2 allele: high-throughput analysis and association with venous thromboembolism. Thromb Haemost 2001; 86(5):1188–92.
  17. Murphy K, Hafez M, Philips J, Yarnell K, Gutshall K, Berg K. Evaluation of temperature gradient capillary electrophoresis for detection of the Factor V Leiden mutation: coincident identification of a novel polymorphism in Factor V. Mol Diagn 2003; 7(1):35–40.
  18. Ozkan D, Erdem A, Kara P et al. Allele-specific genotype detection of factor V Leiden mutation from polymerase chain reaction amplicons based on label-free electrochemical genosensor. Anal Chem 2002; 74(23):5931–6.
  19. Huang TJ, Liu M, Knight LD, Grody WW, Miller JF, Ho CM. An electrochemical detection scheme for identification of single nucleotide polymorphisms using hairpin-forming probes. Nucleic Acids Res 2002; 30(12):e55.
  20. Ozsoz M, Erdem A, Kerman K et al. Electrochemical genosensor based on colloidal gold nanoparticles for the detection of Factor V Leiden mutation using disposable pencil graphite electrodes. Anal Chem 2003; 75(9):2181–7.
  21. Humeny A, Bonk T, Berkholz A, Wildt L, Becker CM. Genotyping of thrombotic risk factors by MALDI-TOF mass spectrometry. Clin Biochem 2001; 34(7):531–6.
  22. Hung K, Sun X, Ding H, Kalafatis M, Simioni P, Guo B. A matrix-assisted laser desorption/ionization time-of-flight based method for screening the 1691G --> A mutation in the factor V gene. Blood Coagul Fibrinolysis 2002; 13(2):117–22.
  23. Pecheniuk NM, Marsh NA, Walsh TP. Multiple analysis of three common genetic alterations associated with thrombophilia. Blood Coagul Fibrinolysis 2000; 11(2):183–9.
  24. Potter CG, Liu YT, Rees DC. Factor V Leiden mutation screened by PCR and detected with lanthanide-labeled probes. Genet Test 2001; 5(4):291–7.
  25. Mammo L, Sheereen A, Saour T, Saour J. Comparative study between the Light Cycler and the PCR-restriction fragment length polymorphism in detecting factor V Leiden and factor II 20210G>A mutations. Clin Biochem 2006; 39(7):767–9.
  26. El Housni H, Heimann P, Parma J, Vassart G. Single-nucleotide polymorphism genotyping by melting analysis of dual-labeled probes: examples using factor V Leiden and prothrombin 20210A mutations. Clin Chem 2003; 49(10):1669–72.
  27. Alsmadi OA, Bornarth CJ, Song W et al. High accuracy genotyping directly from genomic DNA using a rolling circle amplification based assay. BMC Genomics 2003; 4(1):21.
  28. Tsongalis GJ, Rainey BJ, Hodges KA. READIT: a novel technology used in the interrogation of nucleic acid sequences for single-nucleotide polymorphisms. Exp Mol Pathol 2001; 71(3):222–5.
  29. Kowalski A, Radu D, Gold B. Colorimetric microwell plate detection of the factor V Leiden mutation. Clin Chem 2000; 46(8 Pt 1):1195–8.
  30. Simundic AM, Topic E, Stefanovic M. Detection of factor V Leiden by PCR-SSCP using GMA precast Elchrom scientific gels. Clin Appl Thromb Hemost 2003; 9(3):227–31.
  31. Reyes AA, Ugozzoli LA, Lowery JD et al. Linked linear amplification: a new method for the amplification of DNA. Clin Chem 2001; 47(1):31–40.
  32. Evans JG, Lee-Tataseo C. Determination of the factor V Leiden single-nucleotide polymorphism in a commercial clinical laboratory by use of NanoChip microelectronic array technology. Clin Chem 2002; 48(9):1406–11.
  33. Crockett AO, Wittwer CT. Fluorescein-labeled oligonucleotides for real-time pcr: using the inherent quenching of deoxyguanosine nucleotides. Anal Biochem 2001; 290(1):89–97.
  34. Vaughn CP, Elenitoba-Johnson KS. Hybridization-induced dequenching of fluorescein-labeled oligonucleotides: a novel strategy for PCR detection and genotyping. Am J Pathol 2003; 163(1):29–35.
  35. Tripodi A, Chantarangkul V, Menegatti M, Tagliabue L, Peyvandi F. Performance of clinical laboratories for DNA analyses to detect thrombophilia mutations. Clin Chem 2005; 51(7):1310–1.
  36. French C, Li C, Strom C et al. Detection of the factor V Leiden mutation by a modified photo-cross-linking oligonucleotide hybridization assay. Clin Chem 2004; 50(2):296–305.
  37. Rhodes RB, Lewis K, Shultz J et al. Analysis of the factor V Leiden mutation using the READIT Assay. Mol Diagn 2001; 6(1):55–61.

From: Appendix G, Evidence Tables

Cover of Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism
Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism.
Evidence Reports/Technology Assessments, No. 180.
Segal JB, Brotman DJ, Emadi A, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.